Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-12-16

Clinical Trial Update: Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the effects of levothyroxine supplementation in patients with systolic heart failure and subclinical hypothyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Systolic Heart Failure, Sub-clinical Hypothyroidism | Phase 4 | Status: UNKNOWN